Journal of Korean Association of Cancer prevention 2000; 5(2): 65-70
Published online June 30, 2000
© Korean Society of Cancer Prevention
Gil Ho Lee, In Ho Sohng, Hyung Jee Kim and Min Chul Lee1
The effects of aspirin on the urinary bladder carcinogenesis in rats treated with
N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) were studied. The effects of chemoprevention
of aspirin were evaluated with incidence of preneoplastic lesions. Forty-five
female Sprague-Dawley rats were divided into three groups. Group A received 0.05%
BBN in drinking water for 12 weeks. Group B received 0.05% BBN in drinking water with
0.5% aspirin in the diet for 12 weeks. Group C received control diet without added
chemicals. The rats were sacrificed after 12 weeks. There were no typical preneoplastic
lesions in the control group. Preneoplastic lesions such as simple hyperplasia, focal
hyperplasia and papilloma were noted in Group A and B. The incidence of simple
hyperplasia, focal hyperplasia and papilloma in Group A was 100%, 100% and 80%,
respectively. The incidence of simple hyperplasia, focal hyperplasia and papilloma in
Group B were 100%, 100% and 20%. Counts of focal hyperplasia and papilloma lesion
in each rat were significantly reduced in Group B than in Group A (P<0.001). The result
suggests that aspirin significantly decreases the incidence of precancerous lesions
induced with BBN and it can act as an effective cheomopreventive agent for
precancerous lesions in urinary bladder.
Keywords: Carcinogenesis, Bladder tumor, Chemoprevention, Aspirin
Byeongwoo Ahn, Dae Joong Kim and Dong Deuk Jang
Journal of Korean Association of Cancer prevention 2000; 5(2): 94-100Young Sook Hong
Journal of Korean Association of Cancer prevention 2004; 9(4): 215-225Tae Kyung Kim, Chan Young Ock, Jeong Sang Lee and Ki Baik Hahm
Cancer prevention research 2009; 14(3): 177-187